We are live on
!
Find out more
Vanguard Portfolio Management Portfolio holdings
AUM
$2.22T
This Fund
S&P 500
This Quarter
Est. Return
+25.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.22T
AUM Growth
+$305B
(+16%)
Cap. Flow
+$19.5B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
21.57%
Holding
3,286
New
192
Increased
2,077
Reduced
864
Closed
145
Avg Time Held
0.9
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.74B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.66B |
| 3 |
NVIDIA
NVDA
|
+$1.58B |
| 4 |
Micron Technology
MU
|
+$1.23B |
| 5 |
Devon Energy
DVN
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.45B |
| 2 |
Seagate
STX
|
+$2.36B |
| 3 |
Western Digital
WDC
|
+$1.98B |
| 4 |
Honeywell
HON
|
+$1.74B |
| 5 |
Corning
GLW
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Financials | 11.67% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 9.73% |
| 5 | Consumer Discretionary | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2601
Neurogene
NGNE
$530M
| $3.01M | ﹤0.01% |
95,601
+30,521
| +47% | +$840K |
2026 Q1
1 quarter
|
|
2602
Foster
FSTR
$373M
| $3M | ﹤0.01% |
66,408
+9,109
| +16% | +$340K |
2026 Q1
1 quarter
|
|
2603
American Battery Technology Co
ABAT
$292M
| $3M | ﹤0.01% |
1,059,917
-100,862
| -9% | -$323K |
2026 Q1
1 quarter
|
|
2604
Icon
ICLR
$12.7B
| $2.99M | ﹤0.01% |
17,207
+171
| +1% | +$21.8K |
2026 Q1
1 quarter
|
|
2605
Franklin Covey
FC
$206M
| $2.98M | ﹤0.01% |
121,321
+7,657
| +7% | +$175K |
2026 Q1
1 quarter
|
|
2606
Caledonia Mining Corp
CMCL
$472M
| $2.97M | ﹤0.01% |
155,475
-13,284
| -8% | -$302K |
2026 Q1
1 quarter
|
|
|
WYFI
2607
WhiteFiber Inc
WYFI
$612M
| $2.96M | ﹤0.01% |
76,309
+11,341
| +17% | +$274K |
2026 Q1
1 quarter
|
|
2608
Park-Ohio Holdings
PKOH
$702M
| $2.96M | ﹤0.01% |
77,068
+10,996
| +17% | +$338K |
2026 Q1
1 quarter
|
|
|
CTNM
2609
Contineum Therapeutics
CTNM
$496M
| $2.96M | ﹤0.01% |
+180,302
| New | +$2.36M |
2026 Q2
0 quarters
|
|
2610
Codexis
CDXS
$149M
| $2.95M | ﹤0.01% |
1,307,171
+427,832
| +49% | +$1.07M |
2026 Q1
1 quarter
|
|
2611
Korro Bio
KRRO
$156M
| $2.95M | ﹤0.01% |
223,551
+74,992
| +50% | +$932K |
2026 Q1
1 quarter
|
|
2612
Regional Management Corp
RM
$313M
| $2.95M | ﹤0.01% |
71,481
+18,757
| +36% | +$688K |
2026 Q1
1 quarter
|
|
|
FVR
2613
FrontView REIT
FVR
$407M
| $2.94M | ﹤0.01% |
145,427
+26,969
| +23% | +$486K |
2026 Q1
1 quarter
|
|
2614
Designer Brands
DBI
$296M
| $2.94M | ﹤0.01% |
504,460
+63,020
| +14% | +$443K |
2026 Q1
1 quarter
|
|
2615
Atea Pharmaceuticals
AVIR
$414M
| $2.93M | ﹤0.01% |
630,185
+72,606
| +13% | +$361K |
2026 Q1
1 quarter
|
|
2616
Immix Biopharma
IMMX
$770M
| $2.93M | ﹤0.01% |
+283,711
| New | +$2.63M |
2026 Q2
0 quarters
|
|
2617
Akebia Therapeutics
AKBA
$226M
| $2.89M | ﹤0.01% |
2,533,977
+318,536
| +14% | +$379K |
2026 Q1
1 quarter
|
|
|
MMED
2618
MiniMed Group Inc
MMED
$5.57B
| $2.89M | ﹤0.01% |
+193,047
| New | +$2.54M |
2026 Q2
0 quarters
|
|
2619
Contango Silver & Gold Inc
CTGO
$544M
| $2.86M | ﹤0.01% |
181,434
+3,457
| +2% | +$71.2K |
2026 Q1
1 quarter
|
|
2620
Fulcrum Therapeutics
FULC
$286M
| $2.86M | ﹤0.01% |
782,144
+182,765
| +30% | +$1.11M |
2026 Q1
1 quarter
|
|
2621
Clearwater Paper
CLW
$315M
| $2.86M | ﹤0.01% |
182,460
-47,861
| -21% | -$721K |
2026 Q1
1 quarter
|
|
2622
Lexeo Therapeutics
LXEO
$264M
| $2.86M | ﹤0.01% |
613,826
+36,634
| +6% | +$198K |
2026 Q1
1 quarter
|
|
2623
Civeo
CVEO
$330M
| $2.85M | ﹤0.01% |
81,504
+69,731
| +592% | +$2.25M |
2026 Q1
1 quarter
|
|
|
WLTH
2624
Wealthfront Corp
WLTH
$1.7B
| $2.85M | ﹤0.01% |
318,475
+112,680
| +55% | +$1.17M |
2026 Q1
1 quarter
|
|
|
FBRX
2625
DELISTED
Forte Biosciences
FBRX
| $2.84M | ﹤0.01% |
+133,771
| New | +$3.17M |
2026 Q2
0 quarters
|
|
Similar funds
Vanguard Portfolio Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Portfolio Management held 3,286 positions worth $2.22T, up 16% from $1.91T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Vanguard Portfolio Management's Q2 2026 filing shows 192 new, 2,077 increased, 864 reduced and 145 closed positions. Its largest new stake was SpaceX: 10,225,389 shares worth $1.75B. The largest sale was Marvell Technology, an estimated $2.45B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Vanguard Portfolio Management's largest Q2 2026 buy was SpaceX: 10,225,389 shares worth $1.75B.
- Vanguard Portfolio Management added most to NVIDIA in Q2 2026, an estimated $1.58B increase.
- Vanguard Portfolio Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.45B.
- Vanguard Portfolio Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.3B.
- Vanguard Portfolio Management's ten largest holdings make up 22% of its $2.22T portfolio in Q2 2026.
- Vanguard Portfolio Management opened 192 new positions and closed 145 in Q2 2026.
- Vanguard Portfolio Management's portfolio value rose 16% quarter-over-quarter to $2.22T.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.